Voltammetric behavior of nitrofurazone and its hydroxymethyl prodrug with potential anti-Chagas activity

Detalhes bibliográficos
Autor(a) principal: La-Scalea,Mauro Aquiles
Data de Publicação: 2005
Outros Autores: Menezes,Carla Maria de Souza, Julião,Murilo Sérgio da Silva, Chung,Man Chin, Serrano,Sílvia Helena Pires, Ferreira,Elizabeth Igne
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Journal of the Brazilian Chemical Society (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532005000500015
Resumo: Chagas' disease is a serious health problem for Latin America. The situation is worsened by the lack of efficient chemotherapy. The two available commercial drugs, benznidazole and nifurtimox, are more effective in the acute phase of the disease. Nitrofurazone is active against Trypanosoma cruzi, however its high toxicity precludes its current use in parasitosis. Hydroxymethylnitrofurazone is a prodrug of nitrofurazone. It is more active against Trypanosoma cruzi than nitrofurazone, besides being less toxic. This work shows the voltammetric behavior of nitrofurazone and a comparison with those of metronidazole and chloramphenicol using cyclic, linear sweep and differential pulse voltammetries. For these drugs also the prediction of the diffusion coefficients using Wilke-Chang equation was performed. The reduction of nitrofurazone is pH-dependent and in acidic medium the hydroxylamine derivative, involving four electrons, is the principal product formed. In aqueous-alkaline medium and with a glassy carbon electrode pre-treatment the reduction of nitrofurazone occurs in two steps, the first involving one electron to form the nitro-radical anion and the second corresponding to the hydroxylamine derivative formation. Hydroxymethylnitrofurazone presented the same voltammetric behavior and electroactivity, indicating that the molecular modification performed in nitrofurazone did not change its capacity to be reduced. A brief discussion regarding the differences in biological activity between the two compounds is also presented.
id SBQ-2_0a8302fe60a1d4ac03629207d3d14ca1
oai_identifier_str oai:scielo:S0103-50532005000500015
network_acronym_str SBQ-2
network_name_str Journal of the Brazilian Chemical Society (Online)
repository_id_str
spelling Voltammetric behavior of nitrofurazone and its hydroxymethyl prodrug with potential anti-Chagas activitynitrofurazonehydroxymethylnitrofurazonenitrofurazone prodrugcyclic voltammetrynitro-radical anionChagas' disease is a serious health problem for Latin America. The situation is worsened by the lack of efficient chemotherapy. The two available commercial drugs, benznidazole and nifurtimox, are more effective in the acute phase of the disease. Nitrofurazone is active against Trypanosoma cruzi, however its high toxicity precludes its current use in parasitosis. Hydroxymethylnitrofurazone is a prodrug of nitrofurazone. It is more active against Trypanosoma cruzi than nitrofurazone, besides being less toxic. This work shows the voltammetric behavior of nitrofurazone and a comparison with those of metronidazole and chloramphenicol using cyclic, linear sweep and differential pulse voltammetries. For these drugs also the prediction of the diffusion coefficients using Wilke-Chang equation was performed. The reduction of nitrofurazone is pH-dependent and in acidic medium the hydroxylamine derivative, involving four electrons, is the principal product formed. In aqueous-alkaline medium and with a glassy carbon electrode pre-treatment the reduction of nitrofurazone occurs in two steps, the first involving one electron to form the nitro-radical anion and the second corresponding to the hydroxylamine derivative formation. Hydroxymethylnitrofurazone presented the same voltammetric behavior and electroactivity, indicating that the molecular modification performed in nitrofurazone did not change its capacity to be reduced. A brief discussion regarding the differences in biological activity between the two compounds is also presented.Sociedade Brasileira de Química2005-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532005000500015Journal of the Brazilian Chemical Society v.16 n.4 2005reponame:Journal of the Brazilian Chemical Society (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.1590/S0103-50532005000500015info:eu-repo/semantics/openAccessLa-Scalea,Mauro AquilesMenezes,Carla Maria de SouzaJulião,Murilo Sérgio da SilvaChung,Man ChinSerrano,Sílvia Helena PiresFerreira,Elizabeth Igneeng2005-08-25T00:00:00Zoai:scielo:S0103-50532005000500015Revistahttp://jbcs.sbq.org.brONGhttps://old.scielo.br/oai/scielo-oai.php||office@jbcs.sbq.org.br1678-47900103-5053opendoar:2005-08-25T00:00Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ)false
dc.title.none.fl_str_mv Voltammetric behavior of nitrofurazone and its hydroxymethyl prodrug with potential anti-Chagas activity
title Voltammetric behavior of nitrofurazone and its hydroxymethyl prodrug with potential anti-Chagas activity
spellingShingle Voltammetric behavior of nitrofurazone and its hydroxymethyl prodrug with potential anti-Chagas activity
La-Scalea,Mauro Aquiles
nitrofurazone
hydroxymethylnitrofurazone
nitrofurazone prodrug
cyclic voltammetry
nitro-radical anion
title_short Voltammetric behavior of nitrofurazone and its hydroxymethyl prodrug with potential anti-Chagas activity
title_full Voltammetric behavior of nitrofurazone and its hydroxymethyl prodrug with potential anti-Chagas activity
title_fullStr Voltammetric behavior of nitrofurazone and its hydroxymethyl prodrug with potential anti-Chagas activity
title_full_unstemmed Voltammetric behavior of nitrofurazone and its hydroxymethyl prodrug with potential anti-Chagas activity
title_sort Voltammetric behavior of nitrofurazone and its hydroxymethyl prodrug with potential anti-Chagas activity
author La-Scalea,Mauro Aquiles
author_facet La-Scalea,Mauro Aquiles
Menezes,Carla Maria de Souza
Julião,Murilo Sérgio da Silva
Chung,Man Chin
Serrano,Sílvia Helena Pires
Ferreira,Elizabeth Igne
author_role author
author2 Menezes,Carla Maria de Souza
Julião,Murilo Sérgio da Silva
Chung,Man Chin
Serrano,Sílvia Helena Pires
Ferreira,Elizabeth Igne
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv La-Scalea,Mauro Aquiles
Menezes,Carla Maria de Souza
Julião,Murilo Sérgio da Silva
Chung,Man Chin
Serrano,Sílvia Helena Pires
Ferreira,Elizabeth Igne
dc.subject.por.fl_str_mv nitrofurazone
hydroxymethylnitrofurazone
nitrofurazone prodrug
cyclic voltammetry
nitro-radical anion
topic nitrofurazone
hydroxymethylnitrofurazone
nitrofurazone prodrug
cyclic voltammetry
nitro-radical anion
description Chagas' disease is a serious health problem for Latin America. The situation is worsened by the lack of efficient chemotherapy. The two available commercial drugs, benznidazole and nifurtimox, are more effective in the acute phase of the disease. Nitrofurazone is active against Trypanosoma cruzi, however its high toxicity precludes its current use in parasitosis. Hydroxymethylnitrofurazone is a prodrug of nitrofurazone. It is more active against Trypanosoma cruzi than nitrofurazone, besides being less toxic. This work shows the voltammetric behavior of nitrofurazone and a comparison with those of metronidazole and chloramphenicol using cyclic, linear sweep and differential pulse voltammetries. For these drugs also the prediction of the diffusion coefficients using Wilke-Chang equation was performed. The reduction of nitrofurazone is pH-dependent and in acidic medium the hydroxylamine derivative, involving four electrons, is the principal product formed. In aqueous-alkaline medium and with a glassy carbon electrode pre-treatment the reduction of nitrofurazone occurs in two steps, the first involving one electron to form the nitro-radical anion and the second corresponding to the hydroxylamine derivative formation. Hydroxymethylnitrofurazone presented the same voltammetric behavior and electroactivity, indicating that the molecular modification performed in nitrofurazone did not change its capacity to be reduced. A brief discussion regarding the differences in biological activity between the two compounds is also presented.
publishDate 2005
dc.date.none.fl_str_mv 2005-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532005000500015
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532005000500015
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0103-50532005000500015
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Química
publisher.none.fl_str_mv Sociedade Brasileira de Química
dc.source.none.fl_str_mv Journal of the Brazilian Chemical Society v.16 n.4 2005
reponame:Journal of the Brazilian Chemical Society (Online)
instname:Sociedade Brasileira de Química (SBQ)
instacron:SBQ
instname_str Sociedade Brasileira de Química (SBQ)
instacron_str SBQ
institution SBQ
reponame_str Journal of the Brazilian Chemical Society (Online)
collection Journal of the Brazilian Chemical Society (Online)
repository.name.fl_str_mv Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ)
repository.mail.fl_str_mv ||office@jbcs.sbq.org.br
_version_ 1750318166532161536